Prevalence of<unk><unk>  is from 1,400-32,000 (median, 8,800) per 100,000 individuals around the world.<unk><unk>  incidence among patients with newly diagnosed hypertension is 11,200 of per 100,000 individuals. The case-fatality rate of<unk><unk>  is approximately 23.4 per 1,000 individual-years. Patients of all age groups may develop<unk><unk> . There is no racial predilection for<unk><unk> .
Primary hyperaldosteronism epidemiology and demographics
Hypoaldosteronism epidemiology and demographics
Hyperaldosteronism epidemiology and demographics
Primary hyperaldosteronism laboratory findings
Primary hyperaldosteronism pathophysiology
Secondary hyperaldosteronism pathophysiology
Primary hyperaldosteronism MRI Findings
Primary hyperaldosteronism medical therapy